ADPT — Adaptive Biotechnologies Share News
0.000.00%
Last trade - 00:00- $3.35bn
- $3.27bn
- $276.98m
U.S. RESEARCH ROUNDUP- Ansys, Century Communities, Mirati Therapeutics
Adaptive Biotechnologies Corp reports results for the quarter ended in March - Earnings Summary
Brief: Adaptive Biotechnologies Reports First Quarter 2022 Financial Results
Adaptive Biotechnologies Corp expected to post a loss of 45 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Nike, Ebix, Cano Health
Adaptive Bio leaps on reorganization plans, workforce reduction
Brief: Adaptive Biotechnologies Appoints Tycho Peterson As Chief Financial Officer, Reorganizes And Streamlines Workforce
U.S. RESEARCH ROUNDUP-Advance Auto Parts, Airbnb, Marriott
Adaptive Biotechnologies Corp reports results for the quarter ended in December - Earnings Summary
Brief: Adaptive Biotechnologies Reports Fourth Quarter And Full Year 2021 Financial Results
U.S. RESEARCH ROUNDUP-Akumin, Electric last Mile Solutions, PayPal Holdings
Brief: Adaptive Biotechnologies Sees FY 2021 Revenue $153 Mln To $154 Mln
Brief: Adaptive Biotechnologies Announces New Data Demonstrating The Benefit Of Serial Mrd Testing With The Clonoseq® Assay In Patients With Blood Cancers At The 63Rd Ash Annual Meeting
U.S. RESEARCH ROUNDUP-Asana, Entergy, Qualys
Brief: Adaptive Biotechnologies Sees FY Revenue Up 54%
Adaptive Biotechnologies Corp reports results for the quarter ended in September - Earnings Summary
Adaptive Biotechnologies Corp expected to post a loss of 42 cents a share - Earnings Preview
Brief: Adaptive Biotechnologies Says New Data Showing Capability Of Immune Medicine Platform To Distinguish Sars-Cov-2 Infection,Vaccine Response,Detect Lyme Disease
Brief: Adaptive Biotechnologies Launches Enhanced Clonoseq Assay Reports For Patients With Chronic Lymphocytic Leukemia, Now Featuring IGHV Mutation Status